Response to commercial factor VIII concentrate
โ Scribed by Edward D. Gomperts; Doris Menache; George M. Rodgers; Marilyn H. Ford
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 234 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Letters and Correspondence ## 297 percentage of ring sideroblasts in our patients ranged between 15% and 85%. According to our recently published criteria [4], two patients had pure sideroblastic anemia (PSA), which is confined to dyserythropoiesis, and
Factor Vlll (FVIII) replacement by continuous infusion has been advocated as a costeffective method for maintaining stable plasma levels of FVlll in the hemophilia A patient during surgery or lifethreatening hemorrhage. Continuous delivery of monoclonal or recombinant FVlll concentrates to our pedia